A Bayesian Interpretation of CABANA and Other Randomized Controlled Trials for Catheter Ablation in Patients With Atrial Fibrillation.

Background: Catheter ablation improves symptoms and quality of life in atrial fibrillation patients, but its effect on adverse cardiovascular outcomes and mortality remains uncertain. Bayesian analysis of randomized controlled trials offers a deeper understanding of treatment effects beyond conventi...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cardiovascular Electrophysiology Vol. 36; no. 3; pp. 617 - 625
Autores principales: Nogueira, Alleh, Felix, Nicole, Kalil, Felipe, Tramujas, Lucas, Godoi, Amanda, Miyawaki, Isabele A., Bellavia, Andrea, Moura, Filipe A., Cardoso, Rhanderson, d'Avila, André, Fernandes, Gilson C.
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Mar2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183627026&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 183627026
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10453873
        GSB
      jtl: Journal of Cardiovascular Electrophysiology
      issn: 10453873
      maglogo: Y
    pubinfo:
      dt: Mar2025
      vid: 36
      iid: 3
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        183627026
        183627026
        183627026
        10.1111/jce.16552
        183627026
      ppf: 617
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: A Bayesian Interpretation of CABANA and Other Randomized Controlled Trials for Catheter Ablation in Patients With Atrial Fibrillation.
      aug:
        au:
          Nogueira, Alleh
          Felix, Nicole
          Kalil, Felipe
          Tramujas, Lucas
          Godoi, Amanda
          Miyawaki, Isabele A.
          Bellavia, Andrea
          Moura, Filipe A.
          Cardoso, Rhanderson
          d'Avila, André
          Fernandes, Gilson C.
        affil: Department of Medicine, Escola Bahiana de Medicina e Saúde Pública, Salvador Bahia,, Brazil
      sug:
        subj:
          Atrial Fibrillation Therapy
          Catheter Ablation Methods
          Antiarrhythmia Agents Therapeutic Use
          Randomized Controlled Trials
          Human
          Descriptive Statistics
          Data Analysis Software
          Confidence Intervals
          Odds Ratio
          Models, Statistical
          Post Hoc Analysis
          Atrial Fibrillation Prevention and Control
          Quality of Life
          Catheter Ablation Adverse Effects
          Mortality Risk Factors
          Male
          Female
          Adult
          Middle Age
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Background: Catheter ablation improves symptoms and quality of life in atrial fibrillation patients, but its effect on adverse cardiovascular outcomes and mortality remains uncertain. Bayesian analysis of randomized controlled trials offers a deeper understanding of treatment effects beyond conventional p‐value thresholds. Methods: We conducted a post hoc Bayesian reanalysis of CABANA and four similar trials to estimate catheter ablation's effect on cardiovascular and survival outcomes. Using publicly available, trial‐level data, we fitted ordinal Bayesian regression models to assess the impact of catheter ablation on the primary composite outcome—comprising all‐cause mortality, stroke with disability, serious bleeding, and cardiac arrest—as well as mortality alone. We considered two sets of prior distributions: (1) a noninformative prior, where all effect sizes are equally probable and inference is primarily based on trial data, and (2) a treatment effect distribution derived from four trials using a random effects model. Results: In this analysis, refined probability distributions for treatment effects were obtained by integrating data from CABANA with diverse priors through Bayes' theorem, offering a novel, nuanced probabilistic understanding of the potential impact of ablation compared with medical therapy on cardiovascular outcomes and all‐cause mortality. In contrast to CABANA's original frequentist estimates, which were inconclusive, Bayesian analyses indicated probabilities of 82.6% and 81.1% that ablation is superior in reducing adverse cardiovascular outcomes and mortality, respectively. Incorporating results from four other similar trials increased the probability of improved effects on mortality to 86.0%. Conclusions: Bayesian analysis augmented the interpretation of previously inconclusive findings, suggesting a clinically relevant probability of benefit from catheter ablation compared to medical therapy in a broad population with atrial fibrillation.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N